Medical Action Industries Inc. (NASDAQ:MDCI), announced today that it will hold a conference call to present its financial results for the second quarter ended September 30, 2010 on Wednesday, November 3, 2010 at 10:00 a.m. (ET). Paul D. Meringolo, Medical Action’s President and CEO further advised that our results of operations for the quarter ended September 30, 2010 are scheduled to be released on Wednesday, November 3, 2010 before the market opens. A conference call will be conducted by Mr. Meringolo and Mr. Charles L. Kelly, Chief Financial Officer, to discuss Medical Action’s financial results. The conference call will be simultaneously webcast on our website: www.medical-action.com. The dial-in number for the conference call is (888) 334-3932 ( domestic) or (973) 935-8511 ( international); conference ID #17657341. The complete call and discussion will be available for replay on our website beginning at 1:00 p.m. (ET) on November 3, 2010. Medical Action is a diversified manufacturer and distributor of disposable medical devices and a leader in many of the markets where it competes. Its products are marketed primarily to acute care facilities in domestic and certain international markets. The Company has expanded its target market to include physician, dental and veterinary office, out-patient surgery centers, long-term care facilities and laboratories. Medical Action’s products are marketed nationally by its direct sales personnel and extensive network of healthcare distributors. The Company has preferred vendor agreements with national and regional distributors, as well as sole and multi-source agreements with group purchasing organizations. Medical Action’s common stock trades on the NASDAQ Global Select Market under the symbol MDCI and is included in the Russell 2000 Index. This news release contains forward-looking statements that involve risks and uncertainties regarding Medical Action’s operations and future results. Please see the Company’s filings with the Securities and Exchange Commission, including, without limitation, the Company’s Form 10-K and Form 10-Qs, which identify specific factors that would cause actual results or events to differ materially from those described in the forward-looking statements.